Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


28.01.2019

1 Antimicrob Agents Chemother
1 BMJ
1 J Clin Microbiol
12 J Med Microbiol
6 PLoS One
1 Proc Natl Acad Sci U S A
2 Sex Transm Infect


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. CHEN FJ, Huang WC, Liao YC, Wang HY, et al
    Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010-2014.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02007.
    PubMed     Text format     Abstract available


    BMJ

  2. CHAURASIA S, Sivanandan S, Agarwal R, Ellis S, et al
    Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance.
    BMJ. 2019;364:k5314.
    PubMed     Text format    


    J Clin Microbiol

  3. HU P, Zhang H, Fleming J, Zhu G, et al
    Retrospective analysis of false-positive and disputed rifampin resistance Xpert MTB/RIF assay results in clinical samples from a referral hospital in Hunan, China.
    J Clin Microbiol. 2019 Jan 23. pii: JCM.01707-18. doi: 10.1128/JCM.01707.
    PubMed     Text format     Abstract available


    J Med Microbiol

  4. SHINOHARA DR, Menegucci TC, Fedrigo NH, Migliorini LB, et al
    Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study.
    J Med Microbiol. 2019 Jan 21. doi: 10.1099/jmm.0.000920.
    PubMed     Text format     Abstract available

  5. DOUDOULAKAKIS A, Spiliopoulou I, Syridou G, Giormezis N, et al
    Emergence of staphylococcal scalded skin syndrome associated with a new toxinogenic, methicillin-susceptible Staphylococcus aureus clone.
    J Med Microbiol. 2018 Nov 12. doi: 10.1099/jmm.0.000871.
    PubMed     Text format     Abstract available

  6. HAEILI M, Kafshdouz M, Pishnian Z, Feizabadi MM, et al
    Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin.
    J Med Microbiol. 2019;68:60-66.
    PubMed     Text format     Abstract available

  7. KHALIL MAF, Moawad SS, Hefzy EM
    In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    J Med Microbiol. 2019;68:52-59.
    PubMed     Text format     Abstract available

  8. AOKI S, Nakase K, Hayashi N, Noguchi N, et al
    Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    J Med Microbiol. 2019;68:26-30.
    PubMed     Text format     Abstract available

  9. AGHAMALI M, Sedighi M, Zahedi Bialvaei A, Mohammadzadeh N, et al
    Fosfomycin: mechanisms and the increasing prevalence of resistance.
    J Med Microbiol. 2019;68:11-25.
    PubMed     Text format     Abstract available

  10. HORNSEY M, Betts JW, Mehat JW, Wareham DW, et al
    Characterization of a colistin-resistant Avian Pathogenic Escherichia coli ST69 isolate recovered from a broiler chicken in Germany.
    J Med Microbiol. 2019;68:111-114.
    PubMed     Text format     Abstract available

  11. DE AZEVEDO FKSF, Dutra V, Nakazato L, Mello CM, et al
    Molecular epidemiology of multidrug-resistant Acinetobacter baumannii infection in two hospitals in Central Brazil: the role of ST730 and ST162 in clinical outcomes.
    J Med Microbiol. 2019;68:31-40.
    PubMed     Text format     Abstract available

  12. PELTIER F, Choquet M, Decroix V, Adjide CC, et al
    Characterization of a multidrug-resistant Klebsiella pneumoniae ST607-K25 clone responsible for a nosocomial outbreak in a neonatal intensive care unit.
    J Med Microbiol. 2019;68:67-76.
    PubMed     Text format     Abstract available

  13. DOUGLAS AP, Marshall C, Baines SL, Ritchie D, et al
    Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
    J Med Microbiol. 2019 Jan 21. doi: 10.1099/jmm.0.000916.
    PubMed     Text format     Abstract available

  14. DELORME T, Dang D, Garcia A, Nasr P, et al
    Genotypic and phenotypic variations in methicillin-resistant Staphylococcus aureus isolates from outpatient, inpatient and nursing homes.
    J Med Microbiol. 2019 Jan 22. doi: 10.1099/jmm.0.000922.
    PubMed     Text format     Abstract available

  15. BRYANT AE, Gomi S, Katahira E, Huang DB, et al
    The effects of iclaprim on exotoxin production in methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    J Med Microbiol. 2019 Jan 24. doi: 10.1099/jmm.0.000929.
    PubMed     Text format     Abstract available


    PLoS One

  16. SCHEICH S, Koenig R, Wilke AC, Lindner S, et al
    Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival.
    PLoS One. 2018;13:e0201169.
    PubMed     Text format     Abstract available

  17. FAORO C, Wilkinson-White L, Kwan AH, Ataide SF, et al
    Discovery of fragments that target key interactions in the signal recognition particle (SRP) as potential leads for a new class of antibiotics.
    PLoS One. 2018;13:e0200387.
    PubMed     Text format     Abstract available

  18. CONNER JG, Smith J, Erol E, Locke S, et al
    Temporal trends and predictors of antimicrobial resistance among Staphylococcus spp. isolated from canine specimens submitted to a diagnostic laboratory.
    PLoS One. 2018;13:e0200719.
    PubMed     Text format     Abstract available

  19. STANLEY IJ, Kajumbula H, Bazira J, Kansiime C, et al
    Multidrug resistance among Escherichia coli and Klebsiella pneumoniae carried in the gut of out-patients from pastoralist communities of Kasese district, Uganda.
    PLoS One. 2018;13:e0200093.
    PubMed     Text format     Abstract available

  20. JOHNSTON BD, Thuras P, Johnson JR
    Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    PLoS One. 2018;13:e0200442.
    PubMed     Text format     Abstract available

  21. ROOSENHOFF R, van der Vries E, van der Linden A, van Amerongen G, et al
    Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
    PLoS One. 2018;13:e0200849.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  22. DEMERS EG, Biermann AR, Masonjones S, Crocker AW, et al
    Evolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infection.
    Proc Natl Acad Sci U S A. 2018 Nov 2. pii: 1807698115.
    PubMed     Text format     Abstract available


    Sex Transm Infect

  23. COULDWELL DL, Jalocon D, Power M, Jeoffreys NJ, et al
    Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney.
    Sex Transm Infect. 2018;94:406-410.
    PubMed     Text format     Abstract available

  24. CLIFTON S, Town K, Furegato M, Cole M, et al
    Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England.
    Sex Transm Infect. 2018;94:421-426.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: